NASA HI SHIRASO DWARAM: A CONCEPTUAL REFRAMING OF KSHEERABALA TAILA NASYA IN ANIDRA (INSOMNIA) THROUGH THE MODERN NOSE-TO-BRAIN DELIVERY PARADIGM

Background: Nasya, the nasal administration of medicated substances, is among the Panchakarma procedures indicated for Anidra (insomnia), a Vata‑predominant disorder. Its classical rationale rests on the dictum Nasa hi shiraso dwaram (“the nose is the doorway to the head”) and on the Śṛṅgāṭaka Marma, a vital confluence linking the nasal passages to intracranial structures. Ksheerabala Taila, a milk‑ and sesame‑oil‑processed preparation of Bala (Sida cordifolia), is traditionally employed as Brimhana Nasya in Nidranāśa. Objective and hypothesis: This conceptual review examines whether the classical account of Nasya in Anidra corresponds to the modern nose‑to‑brain delivery pathway. It advances the hypothesis that Ksheerabala Taila Nasya functions, in part, as a lipophilic nose‑to‑brain delivery system, conveying centrally active, Vata‑pacifying constituents of Bala to sleep‑regulating centres. Methods: Classical Ayurvedic texts and contemporary pharmaceutical, neuroscientific, and clinical literature were reviewed and synthesised conceptually. Synthesis: Modern pharmaceutics demonstrates that intranasally administered agents can reach the central nervous system directly via the olfactory and trigeminal nerves, bypassing the blood–brain barrier. Lipid‑based vehicles enhance this transport; sesame oil is one such vehicle. Bala contains centrally active phytoconstituents and exhibits CNS‑depressant and monoamine‑modulating activity in experimental models. Preliminary clinical reports of Ksheerabala Taila and other Nasya therapies in insomnia are encouraging but limited. Conclusion: The classical logic of Nasya anticipates, in its own idiom, the modern nose-to-brain paradigm. The proposed mechanism remains a hypothesis, not an established fact, and delineates a clear experimental agenda for future research on the therapeutic potential and neurobiological basis of Nasya.